Table 2.
Case | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Disease status at transplantation | CR | CR | CR | CR | PR | CR | CR | PR | PR | CR | CR | PR |
Conditioning regimen | CVB | CVB | CVB | CVB | CVB | CVB | CVB | CVB | CVB | CVB | CVB | CVB |
Infused CD34+ cells (´106/kg) | 3.52 | 3.344 | 8.098 | 3.928 | 5.44 | 11.31 | 3.5 | 3.1 | 7.1 | 4.84 | 5.21 | 13.8 |
Date of engraftment of neutrophils (days) | 10 | 11 | 9 | 9 | 12 | 11 | 11 | 12 | 13 | 13 | 11 | 11 |
Date of engraftment of platelets (days) | 11 | 11 | 10 | 9 | 12 | 11 | 12 | 18 | 16 | 17 | 11 | 16 |
Relapse (months from HSCT) | - | 33.5 | - | - | - | - | 11.1 | 11.8 | - | 3.3 | - | - |
Final outcome | Survival | Survival | Lost | Survival | Survival | Survival | Survival | Death | Survival | Death | Survival | Survival |